Isolated acrometastasis: A rare presenting feature of endometrial carcinoma

被引:2
作者
Madabhavi, Irappa V. [1 ]
Patel, Apurva [2 ]
Sarkar, Malay S. [3 ]
Modi, Mitul G. [4 ]
Aagre, Suhas [5 ]
机构
[1] Gujarat Canc Res Inst, Dept Med & Pediat Oncol, Ahmadabad, Gujarat, India
[2] Gujarat Canc Res Inst, Dept Med Oncol, Ahmadabad, Gujarat, India
[3] Gujarat Canc Res Inst, Dept Pathol, Ahmadabad, Gujarat, India
[4] Indira Gandhi Med Coll, Dept Pulm Med, Shimla, Himachal Prades, India
[5] Asian Inst Oncol, Dept Med Oncol, Mumbai, Maharashtra, India
关键词
Acrometastasis; endometrial carcinoma; foot metastasis; CALCANEAL METASTASIS; BONE METASTASIS; PHASE-II; CARBOPLATIN; PACLITAXEL; RECURRENT; CANCER; ADENOCARCINOMA; TUMORS; FOOT;
D O I
10.4103/jcrt.JCRT_394_15
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The most common presenting feature of endometrial carcinoma (EC) is abnormal uterine bleeding. Bone metastasis, as a presenting feature of EC, is very unusual which is usually restricted to pelvis and vertebrae. The occurrence of foot metastasis is exceedingly rare. We report a case of a postmenopausal female presented with pain and swelling involving right foot. Biopsy revealed metastatic adenocarcinoma. The patient denied any history of vaginal bleeding or other gynecological symptoms. Bone scan suggested increased uptake in multiple tarsal bones. Uterine curettage confirmed the diagnosis of endometrial adenocarcinoma. The patient was successfully treated with debulking surgery, palliative radiotherapy to the right foot, bisphosphonates, and systemic chemotherapy with marked improvement in local symptoms and is under follow-up for the last 6 months after completion of the treatment. An extensive review of the literature, to the best of our knowledge, did not reveal many cases of acrometastasis as a presenting feature of EC.
引用
收藏
页码:1402 / 1404
页数:3
相关论文
共 16 条
[11]   Randomized phase II study comparing docetaxel plus cisplatin, docetaxel plus carboplatin, and paclitaxel plus carboplatin in patients with advanced or recurrent endometrial carcinoma: a Japanese Gynecologic Oncology Group study (JGOG2041) [J].
Nomura, H. ;
Aoki, D. ;
Takahashi, F. ;
Katsumata, N. ;
Watanabe, Y. ;
Konishi, I. ;
Jobo, T. ;
Hatae, M. ;
Hiura, M. ;
Yaegashi, N. .
ANNALS OF ONCOLOGY, 2011, 22 (03) :636-642
[12]   Carboplatin and paclitaxel in advanced or metastatic endometrial cancer [J].
Pectasides, D. ;
Xiros, N. ;
Papaxoinis, G. ;
Pectasides, E. ;
Sykiotis, C. ;
Koumarianou, A. ;
Psyrri, A. ;
Gaglia, A. ;
Kassanos, D. ;
Gouveris, P. ;
Panayiotidis, J. ;
Fountzilas, G. ;
Economopoulos, T. .
GYNECOLOGIC ONCOLOGY, 2008, 109 (02) :250-254
[13]  
Price FV, 1997, SEMIN ONCOL, V24, P78
[14]   Paclitaxel and carboplatin with amifostine in advanced, recurrent, or refractory endometrial adenocarcinoma: a phase II study of the Southwest Oncology Group [J].
Scudder, SA ;
Liu, PY ;
Wilczynski, SP ;
Smith, HO ;
Jiang, C ;
Hallum, AV ;
Smith, GB ;
Hannigan, EV ;
Markman, M ;
Alberts, DS .
GYNECOLOGIC ONCOLOGY, 2005, 96 (03) :610-615
[15]   Endometrial Cancer Diagnosed by the Presence of Bone Metastasis and Treated with Zoledronic Acid: A Case Report and Review of the Literature [J].
Shigemitsu, Aiko ;
Furukawa, Naoto ;
Koike, Natsuki ;
Kobayashi, Hiroshi .
CASE REPORTS IN ONCOLOGY, 2010, 3 (03) :471-476
[16]   Paclitaxel and carboplatin in the treatment of advanced or recurrent endometrial cancer: a large retrospective study [J].
Sovak, M. A. ;
Dupont, J. ;
Hensley, M. L. ;
Ishill, N. ;
Gerst, S. ;
Abu-Rustum, N. ;
Anderson, S. ;
Barakat, R. ;
Konner, J. ;
Poyner, E. ;
Sabbatini, P. ;
Spriggs, D. R. ;
Aghajanian, C. .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2007, 17 (01) :197-203